Jason X. Cheng to Adenocarcinoma
This is a "connection" page, showing publications Jason X. Cheng has written about Adenocarcinoma.
Connection Strength
0.604
-
Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma. Chronobiol Int. 2016; 33(2):210-9.
Score: 0.315
-
Neoadjuvant bevacizumab and chemoradiotherapy in locally advanced rectal cancer: early outcome and technical impact on toxicity. World J Surg Oncol. 2014 Nov 06; 12:329.
Score: 0.289